Nourianz vs. Requip

Are Nourianz and Requip the Same Thing?

Nourianz (istradefylline) and Requip (ropinirole) are used to treat different aspects of Parkinson's disease.

Nourianz is indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease experiencing "off" episodes.

Requip is used to treat symptoms of Parkinson's disease, and is also used to treat restless legs syndrome (RLS).

Nourianz and Requip belong to different drug classes. Nourianz is an adenosine receptor antagonist and Requip is a non-ergoline dopamine agonist.

Side effects of Nourianz and Requip that are similar include dizziness, constipation, nausea, and sleep problems (insomnia).

Side effects of Nourianz that are different from Requip include involuntary muscle movements and hallucinations.

Side effects of Requip that are different from Nourianz include vomiting, stomach pain, loss of appetite, worsened RLS symptoms early in the morning, diarrhea, dry mouth, sweating, headache, drowsiness, agitation, anxiety, flushing, weakness, chest pain, leg swelling, high or low blood pressure, lightheadedness or fainting, muscle spasm, numbness, spinning sensation, abdominal pain, indigestion, gas, palpitations, fast heart rate, sore throat, urinary tract infection (UTI), and vision problems.

Nourianz may interact with itraconazole, ketoconazole, clarithromycin, rifampin, St. John's wort, midazolam, atorvastatin, seizure medications, and digoxin.

Requip may interact with levodopa, ciprofloxacin, fluvoxamine, metoclopramide, omeprazole, medications used to treat nausea and vomiting or mental illness, and estrogen.

What Are Possible Side Effects of Nourianz?

Common side effects of Nourianz include:

  • involuntary muscle movements,
  • dizziness,
  • constipation,
  • nausea,
  • hallucinations, and
  • insomnia

What Are Possible Side Effects of Requip?

Common side effects of Requip include:

  • nausea,
  • vomiting,
  • stomach pain,
  • loss of appetite,
  • worsened RLS symptoms early in the morning,
  • diarrhea,
  • constipation,
  • dry mouth,
  • sweating,
  • headache,
  • dizziness,
  • drowsiness,
  • sleep problems (insomnia),
  • agitation,
  • anxiety,
  • flushing,
  • weakness,
  • chest pain,
  • leg swelling,
  • high or low blood pressure,
  • lightheadedness or fainting,
  • muscle spasm,
  • numbness,
  • spinning sensation,
  • abdominal pain,
  • indigestion,
  • gas,
  • palpitations,
  • fast heart rate,
  • sore throat,
  • urinary tract infection, or
  • vision problems.

What Is Nourianz?

Nourianz (istradefylline) is an adenosine receptor antagonist indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease (PD) experiencing "off" episodes.

What Is Requip?

Requip (ropinirole) is a non-ergoline dopamine agonist used to treat symptoms of Parkinson's disease, such as stiffness, tremors, muscle spasms, and poor muscle control. Requip is also used to treat restless legs syndrome (RLS). Requip is available in generic form.

QUESTION

Parkinson's disease is only seen in people of advanced age. See Answer

What Drugs Interact With Nourianz?

Nourianz may interact with itraconazole, ketoconazole, clarithromycin, carbamazepine, rifampin, phenytoin, St. John's wort, midazolam, atorvastatin, and digoxin. Nourianz is not recommended for use during pregnancy; it may harm a fetus. Women of childbearing potential are advised to use contraception during treatment with Nourianz. It is unknown if Nourianz passes into breast milk or how it would affect a nursing infant. Consult your doctor before breastfeeding.

What Drugs Interact With Requip?

Requip may interact with levodopa, ciprofloxacin, fluvoxamine, metoclopramide, omeprazole, medication used to treat nausea and vomiting or mental illness, or estrogen. Tell your doctor all medications you use. During pregnancy, Requip should be used only if prescribed. It is not known whether this medication passes into breast milk or if it could harm a nursing baby. Requip may reduce breast milk production. Consult your doctor before breast-feeding. Withdrawal symptoms such as fever, muscle stiffness, and confusion may occur if you stop the medication suddenly or if you change doses.

How Should Nourianz Be Taken?

The recommended dosage of Nourianz is 20 mg orally once daily. The dosage may be increased to a maximum of 40 mg once daily.

How Should Requip Be Taken?

The recommended dose of Requip is 40 to 320 mcg twice daily for adults and 40 to 80 mcg twice daily for children. If you are also using a bronchodilator, use it first before using the beclomethasone inhaler. There may be other drugs that can interact with Requip.

SLIDESHOW

Dementia, Alzheimer's Disease, and Aging Brains See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Kyowa Kirin Co. Nourianz Drug Information.

https://www.nourianz.com/

GSK. Requip Product Information.

https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Requip/pdf/REQUIP-PI-PIL.PDF

Health Solutions From Our Sponsors